Kröller, S.; Schober, J.; Krieg, N.; Dennhardt, S.; Pirschel, W.; Kiehntopf, M.; Conway, E.M.; Coldewey, S.M.
The Role of the N-Terminal Domain of Thrombomodulin and the Potential of Recombinant Human Thrombomodulin as a Therapeutic Intervention for Shiga Toxin-Induced Hemolytic-Uremic Syndrome. Toxins 2024, 16, 409.
https://doi.org/10.3390/toxins16090409
AMA Style
Kröller S, Schober J, Krieg N, Dennhardt S, Pirschel W, Kiehntopf M, Conway EM, Coldewey SM.
The Role of the N-Terminal Domain of Thrombomodulin and the Potential of Recombinant Human Thrombomodulin as a Therapeutic Intervention for Shiga Toxin-Induced Hemolytic-Uremic Syndrome. Toxins. 2024; 16(9):409.
https://doi.org/10.3390/toxins16090409
Chicago/Turabian Style
Kröller, Sarah, Jana Schober, Nadine Krieg, Sophie Dennhardt, Wiebke Pirschel, Michael Kiehntopf, Edward M. Conway, and Sina M. Coldewey.
2024. "The Role of the N-Terminal Domain of Thrombomodulin and the Potential of Recombinant Human Thrombomodulin as a Therapeutic Intervention for Shiga Toxin-Induced Hemolytic-Uremic Syndrome" Toxins 16, no. 9: 409.
https://doi.org/10.3390/toxins16090409
APA Style
Kröller, S., Schober, J., Krieg, N., Dennhardt, S., Pirschel, W., Kiehntopf, M., Conway, E. M., & Coldewey, S. M.
(2024). The Role of the N-Terminal Domain of Thrombomodulin and the Potential of Recombinant Human Thrombomodulin as a Therapeutic Intervention for Shiga Toxin-Induced Hemolytic-Uremic Syndrome. Toxins, 16(9), 409.
https://doi.org/10.3390/toxins16090409